U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 9-15, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 9-15, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 06/13/2024
Location: Virtual
Subject: Public Meeting: Optimizing FDA's Use of Processes for Advisory Committees
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, government, and other registered attendees

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 06/09/2024
Location: Grand Rapids, MI
Subject: 128th Association of Food and Drug Officials (AFDO) Annual Educational Conference; Keynote: FDA Human Foods Program Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Food professionals from government, states, academia, consumer groups, and manufacturing

Event Date: 06/11/2024
Location: Washington, DC
Subject: American Bakers Association Policy Conference; Speaker: FDA Foods Program Update
FDA Participant/Group: N/A
Non FDA Participant/Group: American Bakers Association staff and member companies

Event Date: 06/12/2024
Location: Washington, DC
Subject: Plant Based Foods Association Event; Speaker: Plant Based Foods
FDA Participant/Group: N/A
Non FDA Participant/Group: Plant Based Foods Association staff and member companies

Event Date: 06/12/2024
Location: College Park, MD
Subject: Food Chemicals Reviews
FDA Participant/Group: STEVEN MUSSER; KARI BARRETT; KRISTI MULDOON JACOBS;
Non FDA Participant/Group: Aviva Musicus, Jannah Tauheed, Jensen Jose, Peter Lurie, Sarah Sorscher, Thomas Galligan (Center for Science in the Public Interest);

Event Date: 06/13/2024
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Safe Food Coalition to include consumer, public health, research, and labor organizations

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 06/12/2024
Location: Washington, DC
Subject: National Regulatory Authorities of Regional Reference (NRAr) Meeting; Speaker: Regulatory Convergence and Alignment With International Standards
FDA Participant/Group: JOHN WEINER; VESA VUNIQI; ANA PINEDA ZAVALETA; MICHELLE RODRIGUEZ;
Non FDA Participant/Group: Attendees of the National Regulatory Authorities of Regional Reference (NRAr) Meeting

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

Event Date: 06/10/2024
Location: Grand Rapids, MI
Subject: 128th Association of Food and Drug Officials (AFDO) Annual Educational Conference; Speaker: ORA Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Food professionals from government, states, academia, consumer groups, and manufacturing

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 06/13/2024
Location: Washington, DC
Subject: Consumer Healthcare Products Association (CHPA) Board of Directors Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: CHPA Board of Directors

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/11/2024
Location: Virtual
Subject: St. Jude's International Conference on Cellular Immunotherapy in Pediatric Immuno-Oncology (CIPO); Speaker: Facilitating Development of the Next Generation of Cellular Immunotherapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Research and patient advocate stakeholders

Event Date: 06/12/2024
Location: Virtual
Subject: Wake Forest Institute for Regenerative Medicine Annual Regenerative Medicine Essentials Course; Speaker: FDA Efforts to Advance Cell and Gene Therapy Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Research, academic, healthcare, government, industry, and patient advocate stakeholders

Event Date: 06/13/2024
Location: Virtual
Subject: Listening Session
FDA Participant/Group: ANNE EDER;
Non FDA Participant/Group: Members of America’s Blood Centers

Event Date: 06/13/2024
Location: Tysons Corner, VA
Subject: Centre for Innovation in Regulatory Science (CIRS) Workshop - Vaccines - Are Regulatory and Funding Approaches Fit for Purpose for the Next Decade?; Speaker: Vaccines for Adults
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, academic, government, and healthcare stakeholders

Event Date: 06/13/2024
Location: Virtual
Subject: China Symposium of Gene and Cell Therapies; Speaker: FDA Considerations for the Development of Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, academic, and government stakeholders

Event Date: 06/14/2024
Location: King of Prussia, PA
Subject: 2024 @Philly Cell and Gene Therapy Conference; Keynote: Advancing the Development of Novel Biologic Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and research stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 06/13/2024
Location: Virtual
Subject: Association of Clinical Research Organizations Board of Directors Meeting; Speaker: CDRH Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Leaders and members of the clinical outsourcing industry

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 06/11/2024
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: ISAAC CARNEY; DAVID EDWARDS; WILLIAM FLYNN; TIMOTHY SCHELL; JENNIFER MURPHY;
Non FDA Participant/Group: Constance Cullman, Leah Wilkinson (American Feed Industry Association (AFIA));

Event Date: 06/12/2024
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Serval FDA staff
Non FDA Participant/Group: Reagan-Udall Foundation representatives

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

Event Date: 06/10/2024
Location: Ridgefield, CT
Subject: Regulatory Landscape
FDA Participant/Group: N/A
Non FDA Participant/Group: Employees from Boehringer Ingelheim

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top